News Focus
News Focus
icon url

JONAH 2

04/02/11 12:16 PM

#2242 RE: Drugfalco #2241

For the year ended Dec. 31, 2010, the Company reported total revenues of $3.9 million, with a gross profit of $1.4 million, and total net income profit of $366,569. These numbers represent around a 36% gross profit margin, or a 9% profit on total revenues generated, minus operational expense.

For the year ending 2010 revenues increased 34% to $3.9 million, compared to $2.9 million for the same period ending Dec. 31, 2009.

For the same year ending period, the Company reported total assets of $1.8 million, which includes $215,711 of operational cash flow, and total liabilities of $891,465, thus resulting in positive shareholder equity of $916,345. In an effort to build transparency for our shareholders, the Company will embark on complying with reporting standards with OTC Markets, LLC to provide our quarterly and annual reports, and upgrade our listing standard to a higher market tier, upon closure and execution of the term sheet agreement.